魏森,高远,许予明,孙石磊

• 1:郑州大学第一附属医院

摘要(Abstract)：

<正>脑白质疏松(leukoaraiosis,LA),又称白质高信号(white matter hyperintensity,WMH),白质脑病或白质疾病等,由Hachinski等[1]在1986年首次提出。随着磁共振的发展,WMH逐渐成为众多研究中LA的代名词。LA在头颅CT上主要是指侧脑室旁的低密度灶,在脑MRI上表现为T1序列上低信号,T2和T2FLAIR序列的高信号[2]。尽管越来越

关键词(KeyWords)： 白质疏松;危险因素

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 魏森,高远,许予明,孙石磊

参考文献(References)：

• [1]Hachinski VC,Potter P,Merskey H.Leuko-araiosis[J].Arch Neurol,1987,44(1):21-23.
• [2]Valdes Hernandez MC,Piper RJ,Bastin ME,et al.Morphologic,distributional,volumetric,and intensity characterization of periventricular hyperintensities[J].AJNR Am J Neuroradiol,2014,35(1):55-62.
• [3]van Swieten JC,Geyskes GG,Derix MM,et al.Hypertension in the elderly is associated with white matter lesions and cognitive decline[J].Ann Neurol,1991,30(6):825-830.
• [4]Wright CB,Paik MC,Brown TR,et al.Total homocysteine is associated with white matter hyperintensity volume:The northern manhattan study[J].Stroke,2005,36(6):1 207-1 211.
• [5]Vermeer SE,van Dijk EJ,Koudstaal PJ,et al.Homocysteine,silent brain infarcts,and white matter lesions:The rotterdam scan study[J].Ann Neurol,2002,51(3):285-289.
• [6]Erten-Lyons D,Woltjer R,Kaye J,et al.Neuropathologic basis of white matter hyperintensity accumulation with advanced age[J].Neurology,2013,81(11):977-983.
• [7]Vermeer SE,Prins ND,den Heijer T,et al.Silent brain infarcts and the risk of dementia and cognitive decline[J].N Engl J Med,2003,348(13):1 215-1 222.
• [8]Ay H,Arsava EM,Rosand J,et al.Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke[J].Stroke,2008,39(5):1 409-1 413.
• [9]Arsava EM,Rahman R,Rosand J,et al.Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke[J].Neurology,2009,72(16):1 403-1 410.
• [10]Hogervorst E,Ribeiro HM,Molyneux A,et al.Plasma homocysteine levels,cerebrovascular risk factors,and cerebral white matter changes(leukoaraiosis)in patients with alzheimer disease[J].Arch Neurol,2002,59(5):787-793.
• [11]Slawek J,Roszmann A,Robowski P,et al.The impact of mri white matter hyperintensities on dementia in parkinson's disease in relation to the homocysteine level and other vascular risk factors[J].Neuro-degener Dis,2013,12(1):1-12.
• [12]Shimomura T,Anan F,Umeno Y,et al.Hyperhomocysteinaemia is a significant risk factor for white matter lesions in japanese type 2diabetic patients[J].Eur J Neurol,2008,15(3):289-294.
• [13]Anan F,Masaki T,Tatsukawa H,et al.The role of homocysteine as a significant risk factor for white matter lesions in japanese women with rheumatoid arthritis[J].Metabolism,2009,58(1):69-73.
• [14]Chou PS,Chen CH,Wu MN,et al.Determinants of cerebral white matter changes in patients with stroke[J].Intern Med J,2015,45(4):390-395.
• [15]Cloonan L,Fitzpatrick KM,Kanakis AS,et al.Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke[J].Atherosclerosis,2015,240(1):149-153.
• [16]Brown WR,Thore CR.Review:Cerebral microvascular pathology in ageing and neurodegeneration[J].Neuropathol Appl Neurobiol,2011,37(1):56-74.
• [17]Moody DM,Brown WR,Challa VR,et al.Periventricular venous collagenosis:Association with leukoaraiosis[J].Radiology,1995,194(2):469-476.
• [18]Brown WR,Moody DM,Challa VR,et al.Venous collagenosis and arteriolar tortuosity in leukoaraiosis[J].J Neurol Sci,2002,203(204):159-163.
• [19]Buijs PC,Krabbe-Hartkamp MJ,Bakker CJ,et al.Effect of age on cerebral blood flow:Measurement with ungated two-dimensional phase-contrast mr angiography in 250adults[J].Radiology,1998,209(3):667-674.
• [20]van Harten B,de Leeuw FE,Weinstein HC,et al.Brain imaging in patients with diabetes:A systematic review[J].Diabetes Care,2006,29(11):2 539-2 548.
• [21]Nobili F,Rodriguez G,Marenco S,et al.Regional cerebral blood flow in chronic hypertension.A correlative study[J].Stroke,1993,24(8):1 148-1 153.
• [22]Firbank MJ,Wiseman RM,Burton EJ,et al.Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure.Brain atrophy,wmh change and blood pressure[J].J Neurol,2007,254(6):713-721.
• [23]Godin O,Tzourio C,Maillard P,et al.Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes:The three-city(3c)-dijon magnetic resonance imaging study[J].Circulation,2011,123(3):266-273.
• [24]Del Bene A,Ciolli L,Borgheresi L,et al.Is type 2diabetes related to leukoaraiosis?An updated review[J].Acta Neurol Scand,2015,132(3):147-155.
• [25]Liu DS,Gao W,Liang ES,et al.Effects of allicin on hyperhomocysteinemia-induced experimental vascular endothelial dysfunction[J].Eur J Pharmacol,2013,714(1/3):163-169.
• [26]Leung SB,Zhang H,Lau CW,et al.Salidroside improves homocysteine-induced endothelial dysfunction by reducing oxidative stress[J].Evid Based Complement Alternat Med,2013,2013:679 635.
• [27]Seshadri S,Wolf PA,Beiser AS,et al.Association of plasma total homocysteine levels with subclinical brain injury:Cerebral volumes,white matter hyperintensity,and silent brain infarcts at volumetric magnetic resonance imaging in the framingham offspring study[J].Arch Neurol,2008,65(5):642-649.
• [28]Warner DS,Sheng H,Batinic-Haberle I.Oxidants,antioxidants and the ischemic brain[J].J Exp Biol,2004,207(Pt 18):3 221-3 231.
• [29]Schretlen DJ,Inscore AB,Vannorsdall TD,et al.Serum uric acid and brain ischemia in normal elderly adults[J].Neurology,2007,69(14):1 418-1 423.
• [30]Shih CY,Chen CY,Wen CJ,et al.Relationship between serum uric acid and cerebral white matter lesions in the elderly[J].Nutr Metab Cardiovasc Dis,2012,22(2):154-159.
• [31]Han SW,Song TJ,Bushnell CD,et al.Serum uric acid is associated with cerebral white matter hyperintensities in patients with acute lacunar infarction[J].J Neuroimaging,2016,26(3):351-354.
• [32]Stocker R,Yamamoto Y,McDonagh AF,et al.Bilirubin is an antioxidant of possible physiological importance[J].Science,1987,235(4 792):1 043-1 046.
• [33]Park BJ,Shim JY,Lee HR,et al.Association between serum total bilirubin level and leukoaraiosis in korean adults[J].Clin Biochem,2012,45(4-5):289-292
• [34]Wollenweber FA,Zietemann V,Gschwendtner A,et al.Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke[J].Stroke,2013,44(5):1 446-1 448.
• [35]Schweizer U,Kohrle J.Function of thyroid hormone transporters in the central nervous system[J].Biochim Biophys Acta,2013,1830(7):3 965-3 973.
• [36]Leonards CO,Schneider HJ,Liman TG,et al.Thyroid-stimulating hormone,white matter hyperintensities,and functional outcome in acute ischemic stroke patients[J].Cerebrovasc Dis Extra,2014,4(1):61-68.
• [37]van Dijk EJ,Prins ND,Vrooman HA,et al.Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences:Rotterdam scan study[J].Stroke,2008,39(10):2 712-2 719.